CARECarter Bankshares, Inc.

$30.55+62% 1Y

Is the price fair?

Good

Cheap against its own history. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.

1 good, 2 without data
Vs its own P/E rangecheapest in 22 quartersderived

Cheap vs its own history: P/E 5.3 vs a 12.7 median over 22 quarters (−59% vs median).

Where this answer is blind. The growth-implied estimate assumes a fixed discount rate; capital-heavy sectors look structurally rich on it.

What CARE's price assumes

Carter Bankshares, Inc. trades at 5.26× earnings against 12.3× for the median Banks - Regional name, cheaper than its own group.

5.26

Trailing P/E · Banks - Regional median 12.3 · cheaper than the typical name in its group

Price / sales
3.11

Price / sales · as of 2026-Q2

Price / book
1.38

Price / book · as of 2026-Q2

Details›
Price / bookas of 2026-Q2
1.38
Financial Services median P/E599 names
12.5
Banks - Regional median P/E234 names
12.3
Market capitalisation22.2 million shares, counted Aug 3, 2026
$677M
CARE has re-rated away from its own history, so multiplying the old multiple by today's earnings prices a full reversal, not the business
MethodPer share
What its own history would implynot meaningful, 5.26× today against a 12.7× median
52-week range$16.90 – $35.73
Today$30.55

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.

Against its own past

Its multiples now against their own history, and how much of the price move came from earnings rather than the multiple.